| ID | stock | broker | amount | AVG | BUY TOTAL | date | time | Filled price | amount filled | volume | Total filled | total Stock | Total $ | final price | Remark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | AGTC | RH | 50 | $3.09 | $154.50 | 7/29/2022 | $0.38 | 5,000.00 | 0 | $1,875.00 | 5050 | $2,029.50 | $0.40 |
| ID | stock | broker | amount | AVG | BUY TOTAL | date | time | Filled price | amount filled | volume | Total filled | total Stock | Total $ | final price | Remark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | AGTC | RH | 50 | $3.09 | $154.50 | 7/29/2022 | $0.38 | 1,000.00 | 0 | $375.00 | 1050 | $529.50 | $0.50 |
| ID | stock | broker | amount | AVG | BUY TOTAL | date | time | Filled price | amount filled | volume | Total filled | total Stock | Total $ | final price | Remark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | AGTC | RH | 50 | $3.09 | $154.50 | 7/29/2022 | $0.38 | 500.00 | 0 | $187.50 | 550 | $342.00 | $0.62 |
Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. The listed name for AGTC is Applied Genetic Technologies Corporation Common Stock.
No comments:
Post a Comment